1
Home
Companies

ANI Pharmaceuticals

#4678

Rank

$1.57B

Marketcap

US United States

Country

ANI Pharmaceuticals
Leadership team

Mr. Nikhil Lalwani (Pres, CEO & Director)

Mr. Stephen P. Carey (CFO, Sr. VP of Fin. & Corp. Sec.)

Mr. James G. Marken (Sr. VP of Operations & Product Devel.)

Products/ Services
Biotechnology, Health Care, Manufacturing, Pharmaceutical
Number of Employees
500 - 1000
Headquarters
Baudette, Minnesota, United States
Established
1996
Company Registration
SEC CIK number: 0001023024
Revenue
100M - 500M
Traded as
ANIP
Social Media
URL
https://www.anipharmaceuticals.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
History

ANI Pharmaceuticals began in 1979 as specialty generics manufacturer Milestone Pharmaceuticals, with a mission to develop and provide access to high quality and affordable pharmaceuticals. Over the years, Milestone rapidly developed a strong portfolio of generic and branded products and Pharma Tech Solutions, a development and formulation platform designed to help customers bring quality products to market quickly and cost-effectively. In 2007, Milestone changed its name to ANI Pharmaceuticals in order to better reflect our commitment to the highest standards of quality, service, and integrity.

Mission
Our mission is to develop and provide access to high-barrier-to-entry generic products, innovating to bring new therapeutics to market and expanding existing therapeutics to better serve patients and physicians.
Vision
Our vision is to be the industry-leading generic drug developer, innovator and manufacturer of high-barrier-to-entry therapeutics.
Key Team

Mr. Christopher K. Mutz (Head of Rare Disease)

Mr. Chad Gassert (Sr. VP of Corp. Devel. & Strategy)

Ms. Krista L. Davis (Chief HR Officer)

Mr. Ori Gutwerg (Sr. VP of Generics)

Ms. Elizabeth Powell J.D. (Chief Compliance Officer & Head of Legal of Rare Disease)

Mr. Muthusamy Shanmugam MS R.Ph. (Head of R&D, COO of Novitium Operations & Director)

Ms. Meredith W. Cook (Sr. VP, Gen. Counsel & Corp. Sec.)

Recognition and Awards
ANI Pharmaceuticals has been recognized with multiple awards, including the Manufacturing Leadership Award, the National Association of Pharmaceutical Manufacturers STAR Excellence Award, and the Business of the Year award from the Greater Minneapolis St. Paul Regional Chamber of Commerce.
References

https://in.investing.com/equities/biosante-pharmaceuticals-inc

https://www.comparably.com/companies/vision/mission

https://www.crunchbase.com/organization/ani-pharmaceuticals

https://finance.yahoo.com/quote/ANIP/

https://www.anipharmaceuticals.com

https://sec.report/CIK/0001023024

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

ANI Pharmaceuticals
Leadership team

Mr. Nikhil Lalwani (Pres, CEO & Director)

Mr. Stephen P. Carey (CFO, Sr. VP of Fin. & Corp. Sec.)

Mr. James G. Marken (Sr. VP of Operations & Product Devel.)

Products/ Services
Biotechnology, Health Care, Manufacturing, Pharmaceutical
Number of Employees
500 - 1000
Headquarters
Baudette, Minnesota, United States
Established
1996
Company Registration
SEC CIK number: 0001023024
Revenue
100M - 500M
Traded as
ANIP
Social Media
URL
https://www.anipharmaceuticals.com